In recent years, great advances have been made in our understanding of cancer, leading to the successful development of many novel drugs. However, this progress has been accompanied by a substantial increase in drug prices, which has affected the availability of these drugs for patients.1 Additionally, some new drugs have benefits that can be measured in weeks of added life expectancy. In these cases, an alternative view, from the perspective of the health-care system, is that high prices are not...